普雷沃菌属
幽门螺杆菌
轻度链球菌
内科学
医学
耐火材料(行星科学)
链球菌
生物
葡萄球菌
微生物学
胃肠病学
免疫学
肠道菌群
失调
抗菌剂
螺旋藻科
抗生素
作者
Chia-Jung Kuo,Ngoc-Niem Bui,Yuan‐Ming Yeh,Cheng-Yu Lin,Shih-Yu Wu,Wey-Ran Lin,Ming-Ling Chang,Cheng-Tang Chiu,Cheng-Hsun Chiu,Chih‐Ho Lai
标识
DOI:10.1016/j.bj.2026.101023
摘要
Background The relationship between gastric microbiota composition, Helicobacter pylori infection, and eradication outcomes remains unclear. This study aims to explore the association of gastric microbiota composition among patients with refractory H. pylori infection with the outcomes of rescue therapy. Material and Methods Patients who failed to respond to second- or third-line eradication therapies were prospectively enrolled. The composition of the gastric microbiota was analyzed using 16S rRNA gene sequencing prior to rescue therapy. The eradication outcomes were confirmed using the [ 13 C]-urea breath test. Results Among 1,590 screened participants, 23 patients with refractory H. pylori infection who underwent rescue therapy based on antimicrobial susceptibility testing were enrolled. The alpha diversity did not differ between success and failure groups; however, the beta diversity analysis revealed a distinct microbial composition. The success group was enriched in Streptococcus , Neisseria , Cutibacterium , and Staphylococcus , with two significant species, Streptococcus mitis and Streptococcus cristatus . In contrast, Prevotella colorans was enriched in the failure group. Conclusions Distinct gastric microbiota signatures were associated with treatment outcomes in patients with refractory H. pylori infection. These findings provide insights that may facilitate the development of microbiota-based diagnostics and interventions to improve eradication success.
科研通智能强力驱动
Strongly Powered by AbleSci AI